Montefiore Medical Center

NCT07779642

CollaboratorPhase 2Not yet recruiting2026300 people21 Aug 2026clinicaltrials.gov

NCT07228052

Phase 4Recruiting2026182 people13 Nov 2025clinicaltrials.gov

NCT05721027

Phase 4Recruiting2023132 people9 Feb 2023clinicaltrials.gov

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Phase 2Active, not recruiting202317 people12 Aug 2022clinicaltrials.gov

NCT04799015

Phase 4Completed2021162 people16 Mar 2021clinicaltrials.gov

NCT04791943

Phase 2Completed202160 people10 Mar 2021clinicaltrials.gov

NCT04155008

Phase 4Terminated20211 person7 Nov 2019clinicaltrials.gov

NCT04139304

CollaboratorEarly phase 1Recruiting202115 people25 Oct 2019clinicaltrials.gov

NCT04112823

Phase 4Completed2019209 people2 Oct 2019clinicaltrials.gov

NCT03403049

Phase 1Completed201614 people18 Jan 2018clinicaltrials.gov

NCT02989597

Phase 4Terminated201710 people12 Dec 2016clinicaltrials.gov

NCT02953093

Phase 2Terminated201728 people2 Nov 2016clinicaltrials.gov

NCT02847494

Phase 4Completed2016220 people28 Jul 2016clinicaltrials.gov

NCT02653144

Phase 4Completed2016105 people12 Jan 2016clinicaltrials.gov

NCT02328547

Phase 2Completed201548 people31 Dec 2014clinicaltrials.gov

NCT01590017

CollaboratorPhase 2Completed201441 people2 May 2012clinicaltrials.gov

NCT01504867

CollaboratorPhase 2Completed2012400 people6 Jan 2012clinicaltrials.gov

NCT00456300

Phase 2Completed200711 people4 Apr 2007clinicaltrials.gov

NCT00442767

Phase 4Completed20078 people2 Mar 2007clinicaltrials.gov

NCT00231842

Phase 2Completed200330 people4 Oct 2005clinicaltrials.gov